BRPI0511569A - composições e métodos para o tratamento de distúrbio disfórico pré-menstrual - Google Patents
composições e métodos para o tratamento de distúrbio disfórico pré-menstrualInfo
- Publication number
- BRPI0511569A BRPI0511569A BRPI0511569-8A BRPI0511569A BRPI0511569A BR PI0511569 A BRPI0511569 A BR PI0511569A BR PI0511569 A BRPI0511569 A BR PI0511569A BR PI0511569 A BRPI0511569 A BR PI0511569A
- Authority
- BR
- Brazil
- Prior art keywords
- compositions
- methods
- treatment
- dysphoric disorder
- premenstrual dysphoric
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
COMPOSIçõES E MéTODOS PARA O TRATAMENTO DE DISTúRBIO DISFóRICO PRé-MENSTRUAL. A presente invenção refere-se a um método para o tratamento de distúrbio disfórico pré-menstrual através de administração de pelo menos uma progestina e pelo menos um estrogênio a um indivíduo feminina por pelo menos (100) dias.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57465104P | 2004-05-26 | 2004-05-26 | |
PCT/US2005/016180 WO2005117898A1 (en) | 2004-05-26 | 2005-05-09 | Compositions and methods for treatment of premenstrual dysphoric disorder |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0511569A true BRPI0511569A (pt) | 2008-01-02 |
Family
ID=34969878
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0511569-8A BRPI0511569A (pt) | 2004-05-26 | 2005-05-09 | composições e métodos para o tratamento de distúrbio disfórico pré-menstrual |
Country Status (13)
Country | Link |
---|---|
US (1) | US20050272712A1 (pt) |
EP (1) | EP1755618A1 (pt) |
JP (1) | JP2008500340A (pt) |
CN (1) | CN1972692A (pt) |
AR (1) | AR049112A1 (pt) |
AU (1) | AU2005249401A1 (pt) |
BR (1) | BRPI0511569A (pt) |
CA (1) | CA2566811A1 (pt) |
GT (1) | GT200500127A (pt) |
MX (1) | MXPA06013418A (pt) |
PE (1) | PE20060275A1 (pt) |
TW (1) | TW200602063A (pt) |
WO (1) | WO2005117898A1 (pt) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070111975A1 (en) | 2004-10-07 | 2007-05-17 | Duramed Pharmaceuticals, Inc. | Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens |
TW200726473A (en) * | 2005-06-28 | 2007-07-16 | Wyeth Corp | Compositions and methods for treatment of cycle-related symptoms |
EP2475366A1 (en) * | 2009-09-11 | 2012-07-18 | Bayer Pharma Aktiengesellschaft | Substituted (heteroarylmethyl) thiohydantoins as anticancer drugs |
PT2782584T (pt) | 2011-11-23 | 2021-09-02 | Therapeuticsmd Inc | Preparações e terapias de substituição para hormonoterapias naturais combinadas |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
JP2017516768A (ja) | 2014-05-22 | 2017-06-22 | セラピューティックスエムディー インコーポレーテッドTherapeuticsmd, Inc. | 天然の併用ホルモン補充療法剤及び療法 |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
KR20180126582A (ko) | 2016-04-01 | 2018-11-27 | 쎄러퓨틱스엠디, 인코퍼레이티드 | 스테로이드 호르몬 약제학적 조성물 |
DE102019115343A1 (de) * | 2019-06-06 | 2020-12-10 | EVESTRA GmbH | Vaginalring für die hormonelle Kontrazeption |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4291014A (en) * | 1979-01-11 | 1981-09-22 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing estradiol diacetate |
US4438139A (en) * | 1979-08-14 | 1984-03-20 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing estrogens |
US4826831A (en) * | 1983-08-05 | 1989-05-02 | Pre Jay Holdings Limited | Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens |
JPS60174716A (ja) * | 1984-02-21 | 1985-09-09 | Yamanouchi Pharmaceut Co Ltd | パツチ剤 |
US4752478A (en) * | 1984-12-17 | 1988-06-21 | Merck & Co., Inc. | Transdermal system for timolol |
US4855305A (en) * | 1987-03-23 | 1989-08-08 | Applied Medical Research | Compositions and methods of effecting contraception utilizing melatonin |
DE19654609A1 (de) * | 1996-12-20 | 1998-06-25 | Schering Ag | Therapeutische Gestagene zur Behandlung von Premenstrual Dysphoric Disorder |
EP2305230B1 (en) * | 2001-12-05 | 2015-11-04 | Teva Women's Health, Inc. | Oral contraceptives to prevent pregnancy |
PL1635843T3 (pl) * | 2003-06-25 | 2009-06-30 | Bayer Schering Pharma Ag | Hormonalna terapia zastępcza i leczenie depresji obejmujące dienogest |
-
2005
- 2005-05-09 EP EP05746668A patent/EP1755618A1/en not_active Withdrawn
- 2005-05-09 CN CNA2005800153947A patent/CN1972692A/zh active Pending
- 2005-05-09 CA CA002566811A patent/CA2566811A1/en not_active Abandoned
- 2005-05-09 WO PCT/US2005/016180 patent/WO2005117898A1/en not_active Application Discontinuation
- 2005-05-09 AU AU2005249401A patent/AU2005249401A1/en not_active Withdrawn
- 2005-05-09 BR BRPI0511569-8A patent/BRPI0511569A/pt not_active IP Right Cessation
- 2005-05-09 MX MXPA06013418A patent/MXPA06013418A/es unknown
- 2005-05-09 JP JP2007515131A patent/JP2008500340A/ja not_active Withdrawn
- 2005-05-24 AR ARP050102132A patent/AR049112A1/es unknown
- 2005-05-24 PE PE2005000575A patent/PE20060275A1/es not_active Application Discontinuation
- 2005-05-24 GT GT200500127A patent/GT200500127A/es unknown
- 2005-05-24 TW TW094116889A patent/TW200602063A/zh unknown
- 2005-05-26 US US11/138,747 patent/US20050272712A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
PE20060275A1 (es) | 2006-05-26 |
CN1972692A (zh) | 2007-05-30 |
WO2005117898A1 (en) | 2005-12-15 |
EP1755618A1 (en) | 2007-02-28 |
AU2005249401A1 (en) | 2005-12-15 |
MXPA06013418A (es) | 2007-01-23 |
TW200602063A (en) | 2006-01-16 |
AR049112A1 (es) | 2006-06-28 |
US20050272712A1 (en) | 2005-12-08 |
GT200500127A (es) | 2006-03-23 |
JP2008500340A (ja) | 2008-01-10 |
CA2566811A1 (en) | 2005-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0511569A (pt) | composições e métodos para o tratamento de distúrbio disfórico pré-menstrual | |
BRPI0510094A (pt) | uso de flibanserina no tratamento pré-menstrual e outros distúrbios sexuais femininos | |
MX2020007479A (es) | Profármacos de ketamina, composiciones y usos de los mismos. | |
BRPI0609393B8 (pt) | usos de um composto 11-desóxi-prostaglandina | |
TNSN07111A1 (en) | Preparation and use of biphenyl-4-yl- carbonylamino acid derivatives for the treatment of obesity. | |
BRPI0519424A2 (pt) | composiÇÕes e mÉtodos para tratamento de distérbios de proliferaÇço celular | |
CR8380A (es) | Metodos para preparar y utilizar compuestos novedosos de celulas madre y sus conjuntos | |
BR112022012594A2 (pt) | Dosagem de gama-hidroxibutirato (ghb) | |
BRPI0508561A (pt) | 3-'4-heterociclil-1,2,3-triazol-1-il-n-aril-benzamidas como inibidores da produção de citocinas para o tratamento de doenças inflamatórias crÈnicas | |
EP2177224A3 (en) | Agents for preventing and treating disorders involving modulation of the RyR receptors | |
BRPI0508390A (pt) | métodos para tratamento de dor de cáncer de osso através da administração de um antagonista de fator de crescimento de nervo | |
PT1613315E (pt) | Derivados da quinolina-2-ona para o tratamento de doenças das vias aéreas respiratórias | |
BR0318269A (pt) | composições, alvos, métodos e dispositivos para a terapia de distúrbios oculares e perioculares | |
BRPI0513278A (pt) | uso de um composto, composto, composição farmacêutica, processo para produzir um composto, e, método para causar a morte celular através de terapia de ativação por fóton | |
NO20061625L (no) | Behandling og/eller forhindring av urininkontinens ved bruk av prolegemidler av gaba analoger | |
ECSP099695A (es) | Compuestos derivados de estirenilo para tratar enfermedades y trastornos oftalmicos | |
BRPI0512841A (pt) | composições e métodos para o tratamento de infecções patológicas | |
MX353096B (es) | Metodos para tratar el deterioro cognitivo leve (mci) y trastornos relacionados. | |
BR112018070946A2 (pt) | administração de um construto biespecífico que se liga a cd33 e cd3 para uso em um método para o tratamento de leucemia mieloide | |
BRPI0506493A (pt) | combinações terapêuticas | |
BRPI0415179A (pt) | derivados de amida como ligandos de canal de ìon e composições farmacêuticas e métodos de empregar as mesmas | |
BRPI0509653A (pt) | inibidores cinesina mitótica | |
PH12020551076A1 (en) | Methods for treating diabetes, hepatitis, and/or inflammatory liver disease | |
BRPI0520258A2 (pt) | uso de uma composição farmacêutica, método para preparar uma composição farmacêutica, e, uso de uma quantidade eficaz de acetato de eslicarbazepina | |
BR0208052A (pt) | Composição que inibe matriz metaloproteinases para o tratamento de doenças neoplásicas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 6A E 7A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012. |